Epidermal Growth Factor Receptor (EGFR), a receptor tyrosine kinase and member of the ERBB family, is overexpressed in cancers including glioblastoma, head and neck, bladder, non-small cell lung, and breast [1, 2]. This evidence concerns the gene EGFR and glioblastoma.